American Journal of Obstetrics & Gynecology
Volume 198, Issue 6 , Pages 611-619 , June 2008

Maternal obesity and risk of neural tube defects: a metaanalysis

  • Sonja A. Rasmussen, MD, MS

      Affiliations

    • Division of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Susan Y. Chu, PhD, MSPH

      Affiliations

    • Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Shin Y. Kim, MPH

      Affiliations

    • Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Christopher H. Schmid, PhD

      Affiliations

    • Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.
    • ,
  • Joseph Lau, MD

      Affiliations

    • Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.

Received 10 February 2008 ,Accepted 9 April 2008.

References 

  1. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world; a growing challenge. N Engl J Med. 2007;356:213–215
  2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549–1555
  3. Kim SY, Dietz PM, England L, Morrow B, Callaghan WM. Trends in pre-pregnancy obesity in nine states, 1993-2003. Obesity. 2007;15:986–993
  4. Waller DK, Shaw GM, Rasmussen SA, et al. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med. 2007;161:745–750
  5. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics. 2003;111:1152–1158
  6. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med. 1999;341:1509–1519
  7. Anderson JL, Waller DK, Canfield MA, Shaw GM, Watkins ML, Werler MM. Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology. 2005;16:87–92
  8. Hendricks KA, Nuno OM, Suarez L, Larsen R. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology. 2001;12:630–635
  9. Kallen K. Maternal smoking, body mass index, and neural tube defects. Am J Epidemiol. 1998;147:1103–1111
  10. Shaw GM, Todoroff K, Schaffer DM, Selvin S. Maternal height and prepregnancy body mass index as risk factors for selected congenital anomalies. Paediatr Perinat Epidemiol. 2000;14:234–239
  11. Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA. 1996;275:1093–1096
  12. Waller DK, Mills JL, Simpson JL, et al. Are obese women at higher risk for producing malformed offspring?. Am J Obstet Gynecol. 1994;170:541–548
  13. Watkins ML, Scanlon KS, Mulinare J, Khoury MJ. Is maternal obesity a risk factor for anencephaly and spina bifida?. Epidemiology. 1996;7:507–512
  14. Werler MM, Louik C, Shapiro S, Mitchell AA. Prepregnant weight in relation to risk of neural tube defects. JAMA. 1996;275:1089–1092
  15. Feldman B, Yaron Y, Critchfield G, et al. Distribution of neural tube defects as a function of maternal weight: no apparent correlation. Fetal Diagn Ther. 1999;14:185–189
  16. Moore LL, Singer MR, Bradlee ML, Rothman KJ, Milunsky A. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology. 2000;11:689–694
  17. Davidoff MJ, Petrini J, Damus K, Russell RB, Mattison D. Neural tube defect-specific infant mortality in the United States. Teratology. 2002;66(suppl):S17–S22
  18. Ouyang L, Grosse SD, Armour BS, Waitzman NJ. Health care expenditures of children and adults with spina bifida in a privately insured US population. Birth Defects Res A Clin Mol Teratol. 2007;79:552–558
  19. Petterson B, Bourke J, Leonard H, Jacoby P, Bower C. Co-occurrence of birth defects and intellectual disability. Paediatr Perinat Epidemiol. 2007;21:65–75
  20. Oakeshott P, Hunt GM. Long-term outcome in open spina bifida. Br J Gen Pract. 2003;53:632–636
  21. Canfield MA, Collins JS, Botto LD, et al. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol. 2005;73:679–689
  22. Williams LJ, Mai CT, Edmonds LD, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology. 2002;66:33–39
  23. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics. 2005;116:580–586
  24. De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357:135–142
  25. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012
  26. Ray JG, Wyatt PR, Vermeulen MJ, Meier C, Cole DE. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynecol. 2005;105:261–265
  27. Mikhail LN, Walker CK, Mittendorf R. Association between maternal obesity and fetal cardiac malformations in African Americans. J Natl Med Assoc. 2002;94:695–700
  28. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  29. Schmid CH, Stark PC, Berlin JA, Landais P, Lau J. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J Clin Epidemiol. 2004;57:683–697
  30. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian data analysis. New York: Chapman and Hall; 1996;
  31. Andreasen KR, Andersen ML, Schantz AL. Obesity and pregnancy. Acta Obstet Gynecol Scand. 2004;83:1022–1029
  32. Cabrera RM, Hill DS, Etheredge AJ, Finnell RH. Investigations into the etiology of neural tube defects. Birth Defects Res C Embryo Today. 2004;72:330–344
  33. Callaway LK, Prins JB, Chang AM, McIntyre HD. The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Aust. 2006;184:56–59
  34. Castro LC, Avina RL. Maternal obesity and pregnancy outcomes. Curr Opin Obstet Gynecol. 2002;14:601–606
  35. Dietl J. Maternal obesity and complications during pregnancy. J Perinat Med. 2005;33:100–105
  36. Eichholzer M. [Is low or high body weight associated with an increased risk of neural tube defects?]. Schweiz Rundsch Med Prax. 2006;95:2019–2026
  37. Galtier-Dereure F, Boegner C, Bringer J. Obesity and pregnancy: complications and cost. Am J Clin Nutr. 2000;71(suppl):1242S–1248S
  38. Hall LF, Neubert AG. Obesity and pregnancy. Obstet Gynecol Surv. 2005;60:253–260
  39. King JC. Maternal obesity, metabolism, and pregnancy outcomes. Annu Rev Nutr. 2006;26:271–291
  40. Scialli AR. Teratology public affairs committee position paper: maternal obesity and pregnancy. Birth Defects Res A Clin Mol Teratol. 2006;76:73–77
  41. Siega-Riz AM, Siega-Riz AM, Laraia B. The implications of maternal overweight and obesity on the course of pregnancy and birth outcomes. Matern Child Health J. 2006;10(suppl):S153–S156
  42. Waller DK, Dawson TE. Relationship between maternal obesity and adverse pregnancy outcomes. Nestle Nutr Workshop Ser Pediatr Program. 2005;197:211
  43. Garcia-Patterson A, Erdozain L, Ginovart G, et al. In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes. Diabetologia. 2004;47:509–514
  44. Gross T, Sokol RJ, King KC. Obesity in pregnancy: risks and outcome. Obstet Gynecol. 1980;56:446–450
  45. Gutierrez GR, Urbina Ortiz FJ, Ponce de Leon ALP, Amador N. Morbilidad materno-fetal en embarazadas obesas. Ginecol Obstet Mex. 2006;74:483–487
  46. Martinez-Frias ML, Frias JP, Bermejo E, Rodriguez-Pinilla E, Prieto L, Frias JL. Pre-gestational maternal body mass index predicts an increased risk of congenital malformations in infants of mothers with gestational diabetes. Diabet Med. 2005;22:775–781
  47. Mattsson LA, Ladfors L. [Overweight and obesity–a risk factor in pregnancy and labor. Increased frequency of abnormalities, intrauterine death and labor injuries]. Lakartidningen. 2003;100:3959–3961
  48. Naeye RL. Maternal body weight and pregnancy outcome. Am J Clin Nutr. 1990;52:273–279
  49. Richards ID. Congenital malformations and environmental influences in pregnancy. Br J Prev Soc Med. 1969;23:218–225
  50. Shaw GM, Nelson V, Moore CA. Prepregnancy body mass index and risk of multiple congenital anomalies. Am J Med Genet. 2002;107:253–255
  51. Sheiner E, Levy A, Menes TS, Silverberg D, Katz M, Mazor M. Maternal obesity as an independent risk factor for caesarean delivery. Paediatr Perinat Epidemiol. 2004;18:196–201
  52. Suwatanaviroj A, Ratrisawadi V. Factors associated with congenital malformations in Thailand. J Med Assoc Thai. 1996;79:545–549
  53. Watkins ML, Botto LD. Maternal prepregnancy weight and congenital heart defects in offspring. Epidemiology. 2001;12:439–446
  54. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol. 2001;153:961–968
  55. Shaw GM, Quach T, Nelson V, et al. Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr. 2003;78:972–978
  56. Shaw GM, Todoroff K, Finnell RH, Lammer EJ. Spina bifida phenotypes in infants or fetuses of obese mothers. Teratology. 2000;61:376–381
  57. Suarez L, Hendricks KA, Cooper SP, Sweeney AM, Hardy RJ, Larsen RD. Neural tube defects among Mexican Americans living on the US-Mexico border: effects of folic acid and dietary folate. Am J Epidemiol. 2000;152:1017–1023
  58. Velie EM, Shaw GM, Malcoe LH, et al. Understanding the increased risk of neural tube defect-affected pregnancies among Mexico-born women in California: immigration and anthropometric factors. Paediatr Perinat Epidemiol. 2006;20:219–230
  59. Wasserman CR, Shaw GM, Selvin S, Gould JB, Syme SL. Socioeconomic status, neighborhood social conditions, and neural tube defects. Am J Public Health. 1998;88:1674–1680
  60. Basbug M, Serin IS, Ozcelik B, Kula M, Basbug EM, Tutus A. Correlation of elevated leptin levels in amniotic fluid and maternal serum in neural tube defects. Obstet Gynecol. 2003;101:523–528
  61. Friel JK, Frecker M, Fraser FC. Nutritional patterns of mothers of children with neural tube defects in Newfoundland. Am J Med Genet. 1995;55:195–199
  62. Haddow JE, Smith DE, Sever J. Effect of maternal weight on maternal serum alpha-fetoprotein. BJOG. 1982;89:93
  63. Johnson AM, Palomaki GE, Haddow JE. The effect of adjusting maternal serum alpha-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida: a United States collaborative study. Am J Obstet Gynecol. 1990;163:9–11
  64. Pineda-Del Villar L, Martinez-Basalo MC, Delgado W, Prieto-Carrasquero M, Villasmil Y. [Epidemiology of congenital malformations at the Hospital Pedro Garcia Clara, Ciudad Ojeda, Venezuela]. Invest Clin. 1994;35:19–34
  65. Queisser-Luft A, Kieninger-Baum D, Menger H, Stolz G, Schlaefer K, Merz E. [Does maternal obesity increase the risk of fetal abnormalities? Analysis of 20,248 newborn infants of the Mainz Birth Register for detecting congenital abnormalities]. Ultraschall Med. 1998;19:40–44
  66. Wald N, Cuckle H, Boreham J, Terzian E, Redman C. The effect of maternal weight on maternal serum alpha-fetoprotein levels. BJOG. 1981;88:1094–1096
  67. Wald NJ, Cuckle HS. Recent advances in screening for neural tube defects and Down's syndrome. Baillieres Clin Obstet Gynaecol. 1987;1:649–676
  68. Haddow JE, Palomaki GE. Is maternal obesity a risk factor for open neural tube defects?. Am J Obstet Gynecol. 1995;172:245–247
  69. Jovanovic-Peterson L, Peterson CM. Abnormal metabolism and the risk for birth defects with emphasis on diabetes. Ann N Y Acad Sci. 1993;678:228–243
  70. Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the US. Diabetes Care. 2007;30:1562–1566
  71. Polonsky KS, Sturis J, Bell GI. Seminars in medicine of the Beth Israel Hospital, Boston: non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med. 1996;334:777–783
  72. Macintosh MC, Fleming KM, Bailey JA, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333:177
  73. Leguizamon G, Igarzabal ML, Reece EA. Periconceptional care of women with diabetes mellitus. Obstet Gynecol Clin North Am. 2007;34:225–239viii
  74. Hanson U, Persson B, Thunell S. Relationship between haemoglobin A1C in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia. 1990;33:100–104
  75. Ray JG, Thompson MD, Vermeulen MJ, et al. Metabolic syndrome features and risk of neural tube defects. BMC Pregnancy Childbirth. 2007;7:21
  76. Chu SY, Callaghan WM, Kim SY, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30:2070–2076
  77. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2003;26(suppl):S103–S105
  78. Zumoff B, Strain GW. A perspective on the hormonal abnormalities of obesity: are they cause or effect?. Obes Res. 1994;2:56–67
  79. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China: China-US Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341:1485–1490
  80. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects: implications for prevention. JAMA. 1995;274:1698–1702
  81. Mojtabai R. Body mass index and serum folate in childbearing age women. Eur J Epidemiol. 2004;19:1029–1036
  82. Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK. Associations between body mass index and the prevalence of low micronutrient levels among US adults. MedGenMed. 2006;8:59
  83. Carmichael SL, Shaw GM, Schaffer DM, Laurent C, Selvin S. Dieting behaviors and risk of neural tube defects. Am J Epidemiol. 2003;158:1127–1131
  84. Carmichael SL, Shaw GM, Selvin S, Schaffer DM. Diet quality and risk of neural tube defects. Med Hypotheses. 2003;60:351–355
  85. Hendler I, Blackwell SC, Bujold E, et al. The impact of maternal obesity on mid trimester sonographic visualization of fetal cardiac and craniospinal structures. Int J Obes Relat Metab Disord. 2004;28:1607–1611
  86. Wolfe HM, Sokol RJ, Martier SM, Zador IE. Maternal obesity: a potential source of error in sonographic prenatal diagnosis. Obstet Gynecol. 1990;76:339–342
  87. Cragan JD, Khoury MJ. Effect of prenatal diagnosis on epidemiologic studies of birth defects. Epidemiology. 2000;11:695–699
  88. Nieto-Garcia FJ, Bush TL, Keyl PM. Body mass definitions of obesity: sensitivity and specificity using self-reported weight and height. Epidemiology. 1990;1:146–152
  89. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics. 1990;85:1–9
  90. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53:1119–1129

 Reprints not available from the authors.

 The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

PII: S0002-9378(08)00412-2

doi: 10.1016/j.ajog.2008.04.021

American Journal of Obstetrics & Gynecology
Volume 198, Issue 6 , Pages 611-619 , June 2008

Article Tools

* Image Usage & Resolution